The GLP1R rs6923761 variant, GIP receptor pathways, and FTO rs9939609 polymorphisms influence your sensitivity to tirzepatide's appetite-suppressing effects
As your body adjusts to the absence of the medication, symptoms like hunger, weight gain, and high blood sugar (hyperglycemia) may return
Follow-Up and Monitoring After the initial diagnosis and treatment plan are in place, follow-up appointments and monitoring are essential
Recommended to be started in early childhood, PWS growth hormone therapy has several benefits, such as increased height, lower body fat, greater muscle mass, better bone health, and improved physical and cognitive performance
However, similar to SGLT2 inhibitors, the potential mechanisms behind the renal effects of GLP1-RAs still need to be elucidated
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
